Novavax, Inc. Share Price
NVAXNovavax, Inc. Stock Performance
Open $9.44 | Prev. Close $9.23 | Circuit Range N/A |
Day Range $9.39 - $10.75 | Year Range $5.80 - $11.96 | Volume 5,42,032 |
Average Traded $10.34 |
Novavax, Inc. Share Price Chart
About Novavax, Inc.
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Novavax, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
07-May-26 | $9.71 | $9.24 | -1.23% |
06-May-26 | $8.76 | $9.36 | +15.37% |
05-May-26 | $8.09 | $8.11 | +1.11% |
04-May-26 | $8.04 | $8.02 | -0.24% |
01-May-26 | $7.88 | $8.04 | +1.50% |
30-Apr-26 | $8.06 | $7.92 | -0.81% |
29-Apr-26 | $7.81 | $7.99 | +0.69% |